These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 11696435

  • 1. Angiotensin-converting enzyme inhibition prevents glomerular-tubule disconnection and atrophy in passive Heymann nephritis, an effect not observed with a calcium antagonist.
    Benigni A, Gagliardini E, Remuzzi A, Corna D, Remuzzi G.
    Am J Pathol; 2001 Nov; 159(5):1743-50. PubMed ID: 11696435
    [Abstract] [Full Text] [Related]

  • 2. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
    Zoja C, Benigni A, Camozzi D, Corna D, Longaretti L, Todeschini M, Remuzzi G.
    Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy.
    Zoja C, Liu XH, Abbate M, Corna D, Schiffrin EL, Remuzzi G, Benigni A.
    Exp Nephrol; 1998 Sep; 6(2):121-31. PubMed ID: 9567218
    [Abstract] [Full Text] [Related]

  • 4. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C, Corna D, Rottoli D, Cattaneo D, Zanchi C, Tomasoni S, Abbate M, Remuzzi G.
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [Abstract] [Full Text] [Related]

  • 5. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A.
    Exp Nephrol; 1996 May; 4(4):213-21. PubMed ID: 8983642
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C, Abbate M, Corna D, Capitanio M, Donadelli R, Bruzzi I, Oldroyd S, Benigni A, Remuzzi G.
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [Abstract] [Full Text] [Related]

  • 7. The renoprotective properties of angiotensin-converting enzyme inhibitors in a chronic model of membranous nephropathy are solely due to the inhibition of angiotensin II: evidence based on comparative studies with a receptor antagonist.
    Zoja C, Donadelli R, Corna D, Testa D, Facchinetti D, Maffi R, Luzzana E, Colosio V, Bertani T, Remuzzi G.
    Am J Kidney Dis; 1997 Feb; 29(2):254-64. PubMed ID: 9016898
    [Abstract] [Full Text] [Related]

  • 8. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis.
    Benigni A, Tomasoni S, Gagliardini E, Zoja C, Grunkemeyer JA, Kalluri R, Remuzzi G.
    J Am Soc Nephrol; 2001 May; 12(5):941-948. PubMed ID: 11316852
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-converting enzyme inhibition prevents loss of glomerular hydraulic permeability in passive heymann nephritis.
    Remuzzi A, Monaci N, Bonassi ME, Corna D, Zoja C, Mohammed EI, Remuzzi G.
    Lab Invest; 1999 Dec; 79(12):1501-10. PubMed ID: 10616201
    [Abstract] [Full Text] [Related]

  • 10. Angiotensin-converting enzyme inhibition and calcium channel blockade both normalize early hyperfiltration in experimental diabetes, but only the former prevents late renal structural damage.
    Perico N, Amuchastegui CS, Malanchini B, Bertani T, Remuzzi G.
    Exp Nephrol; 1994 Dec; 2(4):220-8. PubMed ID: 8069658
    [Abstract] [Full Text] [Related]

  • 11. How to fully protect the kidney in a severe model of progressive nephropathy: a multidrug approach.
    Zoja C, Corna D, Camozzi D, Cattaneo D, Rottoli D, Batani C, Zanchi C, Abbate M, Remuzzi G.
    J Am Soc Nephrol; 2002 Dec; 13(12):2898-908. PubMed ID: 12444208
    [Abstract] [Full Text] [Related]

  • 12. Effects of anti-proteinuric therapy with angiotensin-converting-enzyme inhibition on renal protein catabolism in the adriamycin-induced nephrotic rat.
    Haas M, de Boer E, de Jong PE, Moolenaar F, Meijer DK, de Zeeuw D.
    Clin Sci (Lond); 2003 Jul; 105(1):51-7. PubMed ID: 12636872
    [Abstract] [Full Text] [Related]

  • 13. ACE inhibition induces regression of proteinuria and halts progression of renal damage in a genetic model of progressive nephropathy.
    Remuzzi A, Fassi A, Bertani T, Perico N, Remuzzi G.
    Am J Kidney Dis; 1999 Oct; 34(4):626-32. PubMed ID: 10516341
    [Abstract] [Full Text] [Related]

  • 14. Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.
    Remuzzi A, Imberti O, Puntorieri S, Malanchini B, Macconi D, Magrini L, Bertani T, Remuzzi G.
    Am J Physiol; 1994 Dec; 267(6 Pt 2):F1034-44. PubMed ID: 7528985
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade on the evolution of spontaneous glomerular injury in male MWF/Ztm rats.
    Remuzzi A, Malanchini B, Battaglia C, Bertani T, Remuzzi G.
    Exp Nephrol; 1996 Dec; 4(1):19-25. PubMed ID: 8788596
    [Abstract] [Full Text] [Related]

  • 16. Sequence of events in the glomerular capillary wall at the onset of proteinuria in passive Heymann nephritis.
    Fujigaki Y, Batsford S, Yamashita F, Yonemura K, Hishida A, Kawachi H, Shimizu F, Vogt A.
    Virchows Arch; 2001 Feb; 438(2):136-45. PubMed ID: 11253115
    [Abstract] [Full Text] [Related]

  • 17. Effect of angiotensin II antagonism on the regression of kidney disease in the rat.
    Remuzzi A, Gagliardini E, Donadoni C, Fassi A, Sangalli F, Lepre MS, Remuzzi G, Benigni A.
    Kidney Int; 2002 Sep; 62(3):885-94. PubMed ID: 12164870
    [Abstract] [Full Text] [Related]

  • 18. Antiproteinuric therapy while preventing the abnormal protein traffic in proximal tubule abrogates protein- and complement-dependent interstitial inflammation in experimental renal disease.
    Abbate M, Zoja C, Rottoli D, Corna D, Perico N, Bertani T, Remuzzi G.
    J Am Soc Nephrol; 1999 Apr; 10(4):804-13. PubMed ID: 10203365
    [Abstract] [Full Text] [Related]

  • 19. Calcium antagonist inhibits glomerular cell apoptosis and injuries of L-NAME exacerbated nephrosclerosis in SHR.
    Watanabe S, Ono H, Ishimitsu T, Matsuoka H, Ono Y, Fujimori T.
    Hypertens Res; 2000 Nov; 23(6):683-91. PubMed ID: 11131282
    [Abstract] [Full Text] [Related]

  • 20. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury.
    Tolins JP, Raij L.
    Hypertension; 1990 Oct; 16(4):452-61. PubMed ID: 2210813
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.